As an obesity medicine physician scientist who regularly cares for patients with complex inflammatory conditions, this study reinforces what many of us have suspected clinically that the benefits of GLP-1 receptor agonists extend well beyond blood sugar control and weight loss and may fundamentally alter the disease trajectory for some of our highest-risk patients. Stanford, who was not involved in this research, is an obesity medicine physician scientist, educator and policy maker at Massachusetts General Hospital and Harvard Medical School, both in Boston
Acute treatment effects were analyzed using unpaired Students t-tests
It is posited that the presence of AOD 9604 could stimulate these chondrocytes to produce more of these vital components
Valvassori SS, Resende WR, Budni J, Dal-Pont GC, Bavaresco DV, Reus GZ, et al
Whether youre a fitness enthusiast, bodybuilder, or simply curious about growth hormone optimization, this article is your go-to resource for understanding the key differences between these two popular peptides